Rupert W Jakes

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Health Information

Randomized Controlled Trial

Platelet Rich Plasma

Chronic Rhinosinusitis

Top Venues

ERJ open research

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Rupert W Jakes, Namhee Kwon, Lynn Huynh, Jeremiah Hwee, Lee Baylis, Rafael Alfonso-Cristancho, Shawn Du, Anamika Khanal, Mei Sheng Duh, Benjamin Terrier
Burden of eosinophilic granulomatosis with polyangiitis in Europe. ERJ open research 10 (4) (2024)
Jeremiah Hwee, Lorraine Harper, Qinggong Fu, Krishnarajah Nirantharakumar, George Mu, Rupert W Jakes
Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK. ERJ open research 10 (3) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Rupert W Jakes, Namhee Kwon, Lynn Huynh, Jeremiah Hwee, Lee Baylis, Rafael Alfonso-Cristancho, Shawn Du, Anamika Khanal, Mei Sheng Duh, Benjamin Terrier
Burden of eosinophilic granulomatosis with polyangiitis in Europe. ERJ open research 10 (4) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Jeremiah Hwee, Lorraine Harper, Qinggong Fu, Krishnarajah Nirantharakumar, George Mu, Rupert W Jakes
Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK. ERJ open research 10 (3) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Johannes A Kroes, Rafael Alfonso-Cristancho, Aruna T Bansal, Emmanuelle Berret, Kristina Bieksiene, Arnaud Bourdin, Luisa Brussino, Diogo Canhoto, Cristina Cardini, Gulfem Celik, Zsuzsanna Csoma, Barbro Dahlén, Ebru Damadoglu, Katrien Eger, Lisa Gauquelin, Bilun Gemicioglu, Ozlem Goksel, Sophie Graff, Enrico Heffler, Hendrik B Hofstee, Peter J Howarth, Rupert W Jakes, Fabienne Jaun, Virginija Kalinauskaite-Zukauske, Peter Kopač, Namhee Kwon, Claudia Chaves Loureiro, Victor Lozoya García, Matthew Masoli, Mariana Paula Rezelj, Luis Pérez De Llano, Sanja Popović-Grle, David Ramos-Barbón, Ana Sà Sousa, Konstantinos Samitas, Florence Schleich, Concetta Sirena, Sabina Skrgat, Eleftherios Zervas, George Zichnalis, Elisabeth H Bel, Jacob K Sont, Simone Hashimoto, Anneke Ten Brinke
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis. ERJ open research 9 (2) (2023)